Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01265
|
|||||
| Drug Name |
Perazine
|
|||||
| Synonyms |
PERAZINE; Pernazine; Taxilan; Psytomin; N-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine; P 725; 10-(3-(4-Methyl-1-piperazinyl)propyl)-10H-phenothiazine; N-Methyl-piperazinyl-N'-propyl-phenothiazin; UNII-8915147A2B; EINECS 201-578-9; Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-; 10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-; NSC638694; N-Methyl-piperazinyl-N'-propyl-phenothiazin [German]; N-Methyl-piperazinylpropyl-phenothiazine; NCGC00159492-02; 10H-Phenothiazine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Schizophrenia [ICD11: 6A20] | Approved | [1] | |||
| Therapeutic Class |
Antipsychotic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H25N3S
|
|||||
| Canonical SMILES |
CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42
|
|||||
| InChI |
InChI=1S/C20H25N3S/c1-21-13-15-22(16-14-21)11-6-12-23-17-7-2-4-9-19(17)24-20-10-5-3-8-18(20)23/h2-5,7-10H,6,11-16H2,1H3
|
|||||
| InChIKey |
WEYVCQFUGFRXOM-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 84-97-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 339.5 | Topological Polar Surface Area | 35 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
4.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:59118
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Perazine for schizophrenia. Cochrane Database Syst Rev. 2014 Jan 15;(1):CD002832. | |||||
| 2 | Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. J Pharm Pharmacol. 2004 Aug;56(8):967-75. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.